STEVENSON, Md.--(BUSINESS WIRE)--The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of CareFusion Corporation (“CareFusion” or the “Company”) (NYSE: CFN) relating to the proposed buyout of the Company by Becton, Dickinson and Company (“BD”).
On October 5, 2014, CareFusion and BD announced a definitive agreement under which BD will acquire CareFusion in a transaction valued at approximately $12.2 billion. Under the terms of the transaction, CareFusion shareholders are anticipated to receive $49.00 in cash and 0.0777 of a share of BD for each share of CareFusion common stock they own. The transaction is expected to close in the first half of calendar year 2015, though CareFusion shareholders will most likely be asked to vote on the transaction well before that time.
The firm’s investigation seeks to determine, among other things, whether the Company’s Board of Directors breached their fiduciary duties by failing to maximize shareholder value before agreeing to enter into the transaction, and whether BD is underpaying for CareFusion shares.
If you currently own common stock of CareFusion and would like to learn more about the investigation being conducted by Brower Piven, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentinvestigations.html. You may also request more information by contacting Brower Piven either by email at email@example.com or by telephone at (410) 415-6616.
Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s.